glp 1 gpcr Selective polypeptide ligand binding to the extracellular surface of the transmembrane domains of the class B GPCRs GLP-1R and GCGR Targeting GLP-1, GIP & GCG
Description
Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used for the management of type 2 diabetes and obesity, yet their long-term cardiovascular effects in high-risk populations continue to be actively evaluated

Abstracts were screened for relevance and full text articles assessed for studies specifically evaluating GLP-1 receptor agonists for binge/purge behaviors in eating disorder populations

Diabetes Obes Metab (2016) 18(8):80311

However, understanding the nuances of how these medications may affect thyroid function and what monitoring is appropriate remains essential for safe and effective treatment

These negotiations have commenced under the Trump administration and are already settled for 2026 and 2027 (CMS, 2025)

The drugs also slow stomach emptying to reduce appetite
